Package 60505-4744-1

Brand: lisdexamfetamine dimesylate

Generic: lisdexamfetamine dimesylate
NDC Package

Package Facts

Identity

Package NDC 60505-4744-1
Digits Only 6050547441
Product NDC 60505-4744
Description

100 CAPSULE in 1 BOTTLE (60505-4744-1)

Marketing

Marketing Status
Marketed Since 2023-11-09
Brand lisdexamfetamine dimesylate
Generic lisdexamfetamine dimesylate
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "7a3783a0-bb54-a95b-99f4-9d3aa9788649", "openfda": {"unii": ["SJT761GEGS"], "rxcui": ["854830", "854834", "854838", "854842", "854846", "854850", "1593856"], "spl_set_id": ["ecad4442-a644-18e3-6ff2-fdbac45eec47"], "manufacturer_name": ["Apotex Corp."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE in 1 BOTTLE (60505-4744-1)", "package_ndc": "60505-4744-1", "marketing_start_date": "20231109"}], "brand_name": "Lisdexamfetamine Dimesylate", "product_id": "60505-4744_7a3783a0-bb54-a95b-99f4-9d3aa9788649", "dosage_form": "CAPSULE", "pharm_class": ["Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulation [PE]"], "product_ndc": "60505-4744", "dea_schedule": "CII", "generic_name": "Lisdexamfetamine Dimesylate", "labeler_name": "Apotex Corp.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Lisdexamfetamine Dimesylate", "active_ingredients": [{"name": "LISDEXAMFETAMINE DIMESYLATE", "strength": "60 mg/1"}], "application_number": "ANDA216944", "marketing_category": "ANDA", "marketing_start_date": "20231109", "listing_expiration_date": "20261231"}